NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Case Medical Issued Patent on Wash Monitoring Device

Case Medical was issued U.S. Patent 9,885,664 for Case Soil, a wash monitoring system that represents the organic soils and bioburden found on surgical instruments that need to be cleaned and prepared for their next use at health care facilities.

“When included as part of the cleaning process, the Case Soil indicator provides sterile processing departments an accurate proxy for the cleanliness and safety of the entire load. It may be used for daily monitoring of cleaning effectiveness in automated washers and ultrasonic machines,” according to a news release.

“Case Soil provides a consistent, reproducible, ‘go, no-go’ method to visually check the performance of automated washers and ultrasonic cleaners as well as the process parameters of multi-enzymatic cleaners and detergents for reprocessing surgical devices” Case Medical CEO Marcia Frieze said. “This process is easy to use, and easy to monitor as failures are instantly recognizable.”

The indicator contains a mixture of sterile blood components, proteins, fat and carbohydrates typically found on surfaces of used medical devices, dried onto a stainless-steel coupon to simulate bioburden. The coupon – with a defined area for inspection – is placed within a hinged stainless-steel holder, representative of a surgical tray.

“Existing wash monitors primarily monitor protein residuals or the effectiveness of alkaline cleaners. However, few, of the currently available indicators monitor pH neutral enzymatic cleaners and the presence of the substrates that they were intended to remove,” according to the news release. “Health care acquired infections have been linked to dirty surgical tools, a major cause of disease transmission from

patient to patient. FDA, AAMI and the CDC issued alerts for better infection prevention methods and monitoring for the well-being of patients, staff and the community at large. The medical device industry has previously used test soils that simulate residues commonly found on surgical devices for validation. However, those commonly used in health care facilities are typically composed of blood only or contain no blood products, rather synthetic materials on a plastic substrate. These are not truly representative of the soils or materials they are supposed to simulate.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X